BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 35728768)

  • 1. Nonalcoholic steatohepatitis and mechanisms by which it is ameliorated by activation of the CNC-bZIP transcription factor Nrf2.
    Bathish B; Robertson H; Dillon JF; Dinkova-Kostova AT; Hayes JD
    Free Radic Biol Med; 2022 Aug; 188():221-261. PubMed ID: 35728768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).
    Sharma RS; Harrison DJ; Kisielewski D; Cassidy DM; McNeilly AD; Gallagher JR; Walsh SV; Honda T; McCrimmon RJ; Dinkova-Kostova AT; Ashford MLJ; Dillon JF; Hayes JD
    Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):367-398. PubMed ID: 29552625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual regulation of transcription factor Nrf2 by Keap1 and by the combined actions of β-TrCP and GSK-3.
    Hayes JD; Chowdhry S; Dinkova-Kostova AT; Sutherland C
    Biochem Soc Trans; 2015 Aug; 43(4):611-20. PubMed ID: 26551701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis.
    Mohs A; Otto T; Schneider KM; Peltzer M; Boekschoten M; Holland CH; Hudert CA; Kalveram L; Wiegand S; Saez-Rodriguez J; Longerich T; Hengstler JG; Trautwein C
    J Hepatol; 2021 Mar; 74(3):638-648. PubMed ID: 33342543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of glycogen synthase kinase-3 enhances NRF2 protein stability, nuclear localisation and target gene transcription in pancreatic beta cells.
    Patibandla C; van Aalten L; Dinkova-Kostova AT; Honda T; Cuadrado A; Fernández-Ginés R; McNeilly AD; Hayes JD; Cantley J; Sutherland C
    Redox Biol; 2024 May; 71():103117. PubMed ID: 38479223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease.
    Tebay LE; Robertson H; Durant ST; Vitale SR; Penning TM; Dinkova-Kostova AT; Hayes JD
    Free Radic Biol Med; 2015 Nov; 88(Pt B):108-146. PubMed ID: 26122708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
    Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
    Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flavonoids from Scutellaria amoena C. H. Wright alleviate mitochondrial dysfunction and regulate oxidative stress via Keap1/Nrf2/HO-1 axis in rats with high-fat diet-induced nonalcoholic steatohepatitis.
    Fang QL; Qiao X; Yin XQ; Zeng YC; Du CH; Xue YM; Zhao XJ; Hu CY; Huang F; Lin YP
    Biomed Pharmacother; 2023 Feb; 158():114160. PubMed ID: 36571996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity.
    Chowdhry S; Zhang Y; McMahon M; Sutherland C; Cuadrado A; Hayes JD
    Oncogene; 2013 Aug; 32(32):3765-81. PubMed ID: 22964642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific targeting of the NRF2/β-TrCP axis promotes beneficial effects in NASH.
    Fernández-Ginés R; Encinar JA; Escoll M; Carnicero-Senabre D; Jiménez-Villegas J; García-Yagüe ÁJ; González-Rodríguez Á; Garcia-Martinez I; Valverde ÁM; Rojo AI; Cuadrado A
    Redox Biol; 2024 Feb; 69():103027. PubMed ID: 38184999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoplastic propels diet-induced NAFL to NASH via ER-mitochondrial tether-controlled redox switch.
    Wei J; Liu J; Wang H; Wen K; Ni X; Lin Y; Huang J; You X; Lei Z; Li J; Shen H; Lin Y
    J Hazard Mater; 2024 Mar; 465():133142. PubMed ID: 38061129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physalin B ameliorates nonalcoholic steatohepatitis by stimulating autophagy and NRF2 activation mediated improvement in oxidative stress.
    Zhang MH; Li J; Zhu XY; Zhang YQ; Ye ST; Leng YR; Yang T; Zhang H; Kong LY
    Free Radic Biol Med; 2021 Feb; 164():1-12. PubMed ID: 33388433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not with insulin resistance.
    Meakin PJ; Chowdhry S; Sharma RS; Ashford FB; Walsh SV; McCrimmon RJ; Dinkova-Kostova AT; Dillon JF; Hayes JD; Ashford ML
    Mol Cell Biol; 2014 Sep; 34(17):3305-20. PubMed ID: 24958099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte-specific sirtuin 6 deletion predisposes to nonalcoholic steatohepatitis by up-regulation of Bach1, an Nrf2 repressor.
    Ka SO; Bang IH; Bae EJ; Park BH
    FASEB J; 2017 Sep; 31(9):3999-4010. PubMed ID: 28536120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte-specific Keap1 deletion reduces liver steatosis but not inflammation during non-alcoholic steatohepatitis development.
    Ramadori P; Drescher H; Erschfeld S; Schumacher F; Berger C; Fragoulis A; Schenkel J; Kensler TW; Wruck CJ; Trautwein C; Kroy DC; Streetz KL
    Free Radic Biol Med; 2016 Feb; 91():114-26. PubMed ID: 26698665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCF/{beta}-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner.
    Rada P; Rojo AI; Chowdhry S; McMahon M; Hayes JD; Cuadrado A
    Mol Cell Biol; 2011 Mar; 31(6):1121-33. PubMed ID: 21245377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of scutellaria-coptis herb couple against non-alcoholic steatohepatitis via activating NRF2 and FXR pathways in vivo and in vitro.
    Xue Y; Wei Y; Cao L; Shi M; Sheng J; Xiao Q; Cheng Z; Luo T; Jiao Q; Wu A; Chen C; Zhong L; Zhang C
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116933. PubMed ID: 37482263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual roles of ULK1 (unc-51 like autophagy activating kinase 1) in cytoprotection against lipotoxicity.
    Park JS; Lee DH; Lee YS; Oh E; Bae KH; Oh KJ; Kim H; Bae SH
    Autophagy; 2020 Jan; 16(1):86-105. PubMed ID: 30907226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway.
    Ou Q; Weng Y; Wang S; Zhao Y; Zhang F; Zhou J; Wu X
    Dig Dis Sci; 2018 Dec; 63(12):3398-3408. PubMed ID: 30191499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SQSTM1/p62 activates NFE2L2/NRF2 via ULK1-mediated autophagic KEAP1 degradation and protects mouse liver from lipotoxicity.
    Lee DH; Park JS; Lee YS; Han J; Lee DK; Kwon SW; Han DH; Lee YH; Bae SH
    Autophagy; 2020 Nov; 16(11):1949-1973. PubMed ID: 31913745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.